Royal Bank of Canada Reaffirms Sector Perform Rating for Sangamo Therapeutics (NASDAQ:SGMO)
Royal Bank of Canada reaffirmed their sector perform rating on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a research report released on Tuesday,Benzinga reports. The firm currently has a $2.00 price objective on the biopharmaceutical company’s stock. Several other equities research analysts have also recently weighed in on the company. Truist Financial decreased […]
Royal Bank of Canada reaffirmed their sector perform rating on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a research report released on Tuesday,Benzinga reports. The firm currently has a $2.00 price objective on the biopharmaceutical company’s stock. Several other equities research analysts have also recently weighed in on the company. Truist Financial decreased […]
